No Data
Universal Health International Group Holding Limited's (HKG:2211) Price Is Right But Growth Is Lacking After Shares Rocket 75%
Xi'an Global Printing (002799.SZ): Focus on the research and development, production, and services of high-end exquisite packaging and related packaging materials for paper products such as Cosmetic, medical instruments, health products, and fast-moving c
On December 18, Gelonghui reported that Xi'an Global Printing (002799.SZ) stated on the investor interactive platform that as a professional pharmaceutical packaging supplier, the company mainly engages in the research and development, production, and sales of pharmaceutical packaging products, and provides clients with integrated packaging solutions including program planning, graphic design, structural design, warehousing management, and Logistics distribution. At the same time, the company focuses on the research and development, production, and services of high-end exquisite paper packaging and related packaging materials for aesthetic cosmetics, medical instruments, health products, fast-moving consumer goods, and other categories.
Tianjin Ringpu Bio-Technology (300119.SZ) plans to spend 0.104 billion yuan to acquire a 56.31% stake in Zhongrui Supply Chain, enhancing the layout of the pet health sector.
Tianjin Ringpu Bio-Technology (300119.SZ) announced that the company intends to acquire Ruipai for 0.104 billion yuan using its own funds or self-raised funds...
Inner Mongolia Yili Industrial Group (600887.SH) plans to participate in the Anhui Jianling Seed Fund, focusing on high-tech innovation and entrepreneurship in the health and wellness field.
Inner Mongolia Yili Industrial Group (600887.SH) announced that its wholly-owned limited partnership Zhuhai Jianling Private Equity Fund Management...
VOLCANO SPRING (01715.HK) plans to establish a joint venture to explore the big health field.
On December 12, Gelonghui reported that VOLCANO SPRING (01715.HK) announced an agreement with Yougu Health Technology to establish a joint venture in China on December 12, 2024, aimed at exploring the big health sector. According to the joint venture agreement, the registered capital will be 1 million yuan. The company and Yougu Health Technology will contribute registered capital of 0.51 million yuan and 0.49 million yuan to the joint venture company respectively. After its establishment, the joint venture company will be 51% owned by the company, and its financial performance will be incorporated into the group's consolidated financial statements.
Awarded the "Annual Outstanding Health Company", hepalink (002399.SZ/9989.HK) interprets value through steady growth.
In today's society, where population aging is becoming increasingly severe, health has become a focal point of great concern. With the enhancement of public health awareness and continuous advancements in technology, a company's innovation capabilities and market performance have become key indicators for measuring its standing in the industry. The global health industry is facing unprecedented development opportunities and challenges. In this context, the 9th "Gelonghui Global Investment Carnival 2025" recently grandly opened, and hepalink, as the leader of the heparin industry chain, won the "Annual Excellence in Global Health Enterprise" award. The "Annual Excellence in Global Health Enterprise" award considers multiple aspects such as product production, service provision, and information dissemination.
